ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0975

Association of HLA-DRB1 Alleles with Ischemic Events and Mortality in a Multi-ethnic Community-living Population

Manmeet Kaur1, Ronit Katz2, Michael H. Criqui1, Maripat Corr1, Wendy S. Post3, Matthew Budoff4, Gerald P. Morris5 and Jan Hughes-Austin5, 1University of California San Diego, San Diego, CA, 2University of Washington, Seattle, WA, 3Johns Hopkins University School of Medicine, Baltimore, MD, 4University of California Los Angeles, Los Angeles, CA, 5University of California San Diego, La Jolla, CA

Meeting: ACR Convergence 2023

Keywords: Cardiovascular, Epidemiology, genetics, Inflammation, risk factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (0965–0992) Epidemiology & Public Health Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Human leukocyte antigen (HLA) DRB1 alleles with specific common amino acids referred to as “the shared epitope (SE)”, have been linked to cardiovascular mortality in inflammatory polyarthritis. Thesehaplotypes associate with ST-elevation myocardial infarction in the general population. However, less is known about the HLA-DRB1 alleles with other cardiovascular (CV) events. We aimed to determine associations of the HLA-DRB1 SE alleles (04:04, 04:05, 04:01, 04:08, 01:01, 14:02, 10:01, 03:01, 03:02) with ischemic events and mortality in a multi-ethnic community-living population.

Methods: Within the Multi-Ethnic Study of Atherosclerosis (MESA), a prospective cohort study designed to determine risk factors and progression of subclinical and clinical CVD, a subset of 955 participants who completed the Abdominal Aortic Calcium Ancillary Study and had complete measures of HLA typing and cardiac imaging were evaluated. We defined shared epitope positive [SE(+)] as being positive for any of the HLA-DRB1 SE alleles; and evaluated associations of SE positivity with all-cause mortality, CVD death (defined as secondary to stroke, coronary heart disease, other atherosclerotic death, or other CVD death), non-CVD death, angina, and myocardial infarction (MI) using Cox proportional hazards models. The covariates in our fully adjusted analysis included age, sex, race/ethnicity, diabetes mellitus, systolic blood pressure, current smoking, ever having cancer, eGFR, current use of anti-hypertensive medications, nonsteroidal anti-inflammatory drugs, and IL-6.

Results: Among the 955 MESA participants, 46% were positive for the shared epitope—38% carried a single allele, and 8% carried two alleles. Average age was 60±9, 47% were women, 51% were White, 9% were Asian, 16% were Black, and 24% were Hispanic/Latino. Age, sex, blood pressure, cholesterol, and inflammatory markers (CRP, TNF-α, IL 6) were similar between the SE(+) and SE(-) participants, but racial distributions differed where SE(+) had a higher proportion of white (51% vs 38%) and lower proportion of Asian (9% vs 17%) and Black (16% vs 21%) participants compared to SE(-). Both SE (+) and (-) had 24% Hispanic/ Latino. Being positive for the SE was not significantly associated with a higher risk of all-cause mortality, CVD death, non-CVD death, angina, or MI compared to those who were SE negative. The mean follow-up time was 15.3 ± 0.9 years.

Conclusion: HLA-DRB1 SE alleles were not associated with a higher risk of ischemic events or mortality in a multi-ethnic community-living population.

Supporting image 1

Associations of HLA-DRB1 alleles with Mortality and CVD Events in the Multi-Ethnic Study of Atherosclerosis


Disclosures: M. Kaur: None; R. Katz: None; M. H. Criqui: None; M. Corr: None; W. S. Post: None; M. Budoff: None; G. P. Morris: CareDx, 5, ThermoFisher/One Lambda, 1, 5, 12, travel support; J. Hughes-Austin: None.

To cite this abstract in AMA style:

Kaur M, Katz R, H. Criqui M, Corr M, S. Post W, Budoff M, P. Morris G, Hughes-Austin J. Association of HLA-DRB1 Alleles with Ischemic Events and Mortality in a Multi-ethnic Community-living Population [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/association-of-hla-drb1-alleles-with-ischemic-events-and-mortality-in-a-multi-ethnic-community-living-population/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-hla-drb1-alleles-with-ischemic-events-and-mortality-in-a-multi-ethnic-community-living-population/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology